Skip to main content
Caplight Logo









Eywa Biotech

Eywa Biotech

Private
MontevideoHealthcare & Life Scienceshttps://eywa.bio

Last Round

Seed

Oct 3, 2025

Total Funding Raised

$2.6M

Company Overview

Eywa Biotech operates in Healthcare & Life Sciences and is based in Montevideo. Its latest recorded funding round was a Seed round in October 2025.

Eywa Biotech is a biotechnology company that develops clinical-grade psychedelic compounds for the treatment of mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clean Manufacturing

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Eywa Biotech Comparables

Compare Eywa Biotech with similar companies based on industry and business-model similarity.

Eywa Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CB Therapeutics
82%
Pharmala Biotech Holdings Inc.
74%
PsyBio Therapeutics Corp
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Eywa Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Victoria Costa Paz

Co-founder & CEO

Founding Team

Pablo Gonzalo Salaverria Izaguirre

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Eywa Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2026

    Grew 27% QoQ, from 11 to 14 employees.

  • May 1, 2026

    Grew 44% QoQ from 9 to 13 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Eywa Biotech Filings

Explore SEC and related filing metadata, where available.

Eywa Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Eywa Biotech's valuation, stock price, and market status.

Is Eywa Biotech a public or private company?

Eywa Biotech is a private company.

What is the current stock price of Eywa Biotech?

Eywa Biotech is a private company, so its shares have no public market price. Caplight tracks Eywa Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Eywa Biotech worth (valuation)?

Valuation information for Eywa Biotech is not publicly available.

Can I buy Eywa Biotech stock?

Eywa Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Eywa Biotech's last funding round?

Eywa Biotech's most recent funding round was Seed on October 3, 2025.

Who are the main investors in Eywa Biotech?

Key investors in Eywa Biotech include Draper Associates.

Will Eywa Biotech IPO soon?

No public IPO plans have been announced for Eywa Biotech.

How can I track Eywa Biotech secondary market activity?

Caplight tracks bids, offers, and trades in Eywa Biotech's shares on secondary markets.

Firmographic Details

HeadquartersMontevideo
Employee Range13
Year Founded2022
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?